May 05, 2025 / 12:00PM GMT
Christopher Gibson - Recursion Pharmaceuticals Inc - Chief Executive Officer, Director
Hi, everybody. My name is Chris Gibson, Co-Founder and CEO of Recursion, and I'm delighted to welcome you to our earnings call this morning. We're going to go ahead and get started.
Perfect. So of course, important to note that we're going to be providing forward-looking information today, so please understand all of these important caveats.
So I want to begin by just talking a little bit about Recursion's mission, which is to decode biology to radically improve lives. And unlike a traditional biotech, where learnings from a program typically work within that specific program, those learnings could improve a program, or the scientists from a given program might take some of those learnings onto their next program.
At Recursion, we're trying to do something different. We're trying to build a learning system, a Recursion operating system, that learns from every program to make the next generation of programs better and better, and that requires some scale. And what you're going to see today is
Q1 2025 Recursion Pharmaceuticals Inc Earnings Call Transcript
May 05, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers